BIO Financial Facts
Net income per share diluted attributable to Bio-Rad: 0.68Net income attributable to Bio-Rad: 19.5M
See Full Income Statement
Total liabilities: 1.43B
Raw materials: 98.51M
See Full Balance Sheet
Earnings History for Bio-Rad Laboratories, Inc. (BIO)
|
Expand Research on BIO
| Next EPS Date | 8/6/13 *Est. | EPS Growth Rate | -37.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +13.9% | Revenue Growth Rate | +2.8% *Last Qtr. |
| Average % Move 1-Wk after EPS | +2.6% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/26/13  |
 |
Q412 | $1.65 | $1.34 | +$0.31 | $573.8M | $558.68M | N/A / N/A | N/A | -1.5% | Details |
| 2/23/12 |
|
Q411 | $2.08 | $1.67 | +$0.41 | $550.2M | $562.06M | N/A / N/A | N/A | +10.8% | Details |
| 2/24/11 |
|
Q410 | $2.41 | $1.35 | +$1.06 | $533.7M | $514.46M | N/A / N/A | N/A | +5.4% | Details |
| 8/2/11 |
|
Q211 | $1.41 | $1.47 | -$0.06 | $521.7M | $508.17M | N/A / N/A | N/A | +11.5% | Details |
| 11/1/11 |
|
Q311 | $1.61 | $1.53 | +$0.08 | $516.5M | $511.47M | N/A / N/A | N/A | +21.4% | Details |
| 8/7/12 |
|
Q212 | $1.69 | $1.19 | +$0.50 | $510.4M | $526.16M | N/A / N/A | N/A | +17.5% | Details |
| 5/7/13 |
|
Q113 | $0.68 | $1.06 | -$0.38 | $499.7M | $506.34M | N/A / N/A | N/A | +3.5% | Details |
| 11/7/12 |
Q312 | $1.48 | $1.17 | +$0.31 | $498.7M | $506.14M | N/A / N/A | N/A | +11.9% | Details |
